These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8411446)

  • 1. Topical effect of intravesical oxybutynin.
    Bonney WW; Robinson RA; Theobald RJ
    J Urol; 1993 Nov; 150(5 Pt 1):1522-5. PubMed ID: 8411446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic studies of intravesical oxybutynin in the rabbit.
    Landau EH; Fung LC; Thorner PS; Mittelman MW; Jayanthi VR; Churchill BM; McLorie GA; Steckler RE; Khoury AE
    J Urol; 1995 Jun; 153(6):2022-4. PubMed ID: 7752387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
    Enzelsberger H; Kurz C; Helmer H
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
    Prasad KV; Vaidyanathan S
    Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder.
    Amark P; Eksborg S; Juneskans O; Bussman G; Palm C
    Br J Urol; 1998 Dec; 82(6):859-64. PubMed ID: 9883225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical oxybutynin affects bladder permeability.
    Ersay A; Demirtas OC
    Int Urol Nephrol; 2001; 32(3):359-61. PubMed ID: 11583352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model).
    Kato K; Kitada S; Chun A; Wein AJ; Levin RM
    J Urol; 1989 Jun; 141(6):1471-5. PubMed ID: 2566693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
    Angelico P; Velasco C; Guarneri L; Sironi G; Leonardi A; Testa R
    BMC Pharmacol; 2005 Oct; 5():14. PubMed ID: 16216132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder.
    Orgen S; Deliktas H; Sahin H; Gedik A; Nergis Y
    Low Urin Tract Symptoms; 2017 Jan; 9(1):52-56. PubMed ID: 28120444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of oxybutynin on lower urinary tract function].
    Nishizawa O; Sugaya K; Suzuki T; Kohama T; Matsuzaki A; Fukuda T; Harada T; Tsuchida S
    Hinyokika Kiyo; 1988 Aug; 34(8):1383-7. PubMed ID: 3195406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
    De Wachter S; Wyndaele JJ
    J Urol; 2003 May; 169(5):1892-5. PubMed ID: 12686868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.